EUVIMEDEUVIMED entdecken
Crossref

Exploring Protein-Protein Interactions: A Promising Avenue for Biomarker and Anti-TB Drug Development

Rajwa D. Suryanto, Maritsa W. A Wumawan, Imam A. Wicaksono

Pharmacology and Clinical Pharmacy Research · 2026-04 · 11 (1)

DOI: 10.15416/pcpr.v11i1.65976 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pharmacology and Clinical Pharmacy Research, 2026-04. Verfasst von Rajwa D. Suryanto und 2 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In 2023, tuberculosis (TB) reached its highest incidence with 8.2 million new cases reported by the World Health Organization (WHO). The virulence of Mycobacterium tuberculosis (MTB) is strongly governed by protein-protein interactions (PPIs) that regulate essential processes such as cell wall biosynthesis, immune evasion, and persistence. This study aims to map and analyze the mechanisms of key PPIs in MTB using a scoping review approach. Data was retrieved from PubChem and related literature with the keyword ``PPIs Network TB''. Our findings highlight crucial PPI-driven mechanisms, including the role of DprE1/DprE2 in arabinogalactan synthesis, VapB4/VapC4 in stress response and self-toxicity, ESX-1 and Type VII Secretion System (T7SS) in virulence factor delivery, and the DosRST system in latent infection. Additionally, host-response proteins such as IL-6 and MMP-9 are identified as potential diagnostic biomarkers. By revealing these molecular interaction pathways, this review provides a roadmap for developing targeted anti-TB drugs and precision diagnostics tailored to MTB strain diversity.

Zitieren

APA

Suryanto, R. D., Wumawan, M. W. A., & Wicaksono, I. A. (2026). Exploring Protein-Protein Interactions: A Promising Avenue for Biomarker and Anti-TB Drug Development. Pharmacology and Clinical Pharmacy Research, 11(1). https://doi.org/10.15416/pcpr.v11i1.65976

Vancouver

Suryanto RD, Wumawan MWA, Wicaksono IA. Exploring Protein-Protein Interactions: A Promising Avenue for Biomarker and Anti-TB Drug Development. Pharmacology and Clinical Pharmacy Research. 2026;11(1). doi:10.15416/pcpr.v11i1.65976

BibTeX
@article{Suryanto2026,
  author = {Suryanto, Rajwa D. and Wumawan, Maritsa W. A and Wicaksono, Imam A.},
  title = {Exploring Protein-Protein Interactions: A Promising Avenue for Biomarker and Anti-TB Drug Development},
  journal = {Pharmacology and Clinical Pharmacy Research},
  year = {2026},
  volume = {11},
  number = {1},
  doi = {10.15416/pcpr.v11i1.65976}
}
Kostenlos starten →